Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Surgical Management Of Ulcerative Colitis: ASCRS Guideline Surgery

Surgical Management Of Ulcerative Colitis: ASCRS Guideline

  • 31 July 2025
  • 3 months ago

Acute Liver Injury Ups Risk Of Severe Hypoglycemia, Mortality In Discharged Diabetes Patients Gastroenterology

Acute Liver Injury Ups Risk Of Severe Hypoglycemia, Mortality In Discharged Diabetes Patients

  • 31 July 2025
  • 3 months ago

Management Of Hemorrhoidal Disease : Surgical Approach Surgery

Management Of Hemorrhoidal Disease : Surgical Approach

  • 31 July 2025
  • 3 months ago

CtDNA Assay Not Reliable For Detecting Recurrence Of Colorectal Cancer After Surgery: JAMA Laboratory Medicine

CtDNA Assay Not Reliable For Detecting Recurrence Of Colorectal Cancer After Surgery: JAMA

  • 31 July 2025
  • 3 months ago

Cuff- And Cap-Assisted Colonoscopy Of No Benefit Over High-Definition Colonoscopy For Adenomas: Study Gastroenterology

Cuff- And Cap-Assisted Colonoscopy Of No Benefit Over High-Definition Colonoscopy For Adenomas: Study

  • 31 July 2025
  • 3 months ago

Seladelpar Effectively Reduces Alkaline Phosphatase Levels In Patients With Primary Biliary Cholangitis Gastroenterology

Seladelpar Effectively Reduces Alkaline Phosphatase Levels In Patients With Primary Biliary Cholangitis

  • 31 July 2025
  • 3 months ago

Semaglutide Shows Promise In Patients With Nonalcoholic Steatohepatitis: NEJM Gastroenterology

Semaglutide Shows Promise In Patients With Nonalcoholic Steatohepatitis: NEJM

  • 31 July 2025
  • 3 months ago

Investigational Drug Effective As Adjunct To PPIs In Refractory GERD Gastroenterology

Investigational Drug Effective As Adjunct To PPIs In Refractory GERD

  • 31 July 2025
  • 3 months ago

Oral Budesonide, An Ideal Option For Drug Treatment Of Eosinophilic Esophagitis: Study Gastroenterology

Oral Budesonide, An Ideal Option For Drug Treatment Of Eosinophilic Esophagitis: Study

  • 31 July 2025
  • 3 months ago

How Regular Exercise Can Protect Against Fatty Liver Associated Diseases Gastroenterology

How Regular Exercise Can Protect Against Fatty Liver Associated Diseases

  • 31 July 2025
  • 3 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Phase III data for Gazyva/Gazyvaro show significan...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.